The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells

被引:283
作者
Carracedo, A
Lorente, M
Egia, A
Blázquez, C
García, S
Giroux, V
Malicet, C
Villuendas, R
Gironella, M
González-Feria, L
Piris, MA
Iovanna, JL
Guzmán, M
Velasco, G [1 ]
机构
[1] Univ Complutense Madrid, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain
[2] INSERM, U624, F-13288 Marseille 9, France
[3] Ctr Nacl Invest Oncol, Inst Salud Carlos III, Madrid 28049, Spain
[4] Univ Hosp, Dept Neurosurg, Tenerife 38320, Spain
关键词
D O I
10.1016/j.ccr.2006.03.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the most exciting areas of current research in the cannabinoid field is the study of the potential application of these compounds as antitumoral drugs. Here, we describe the signaling pathway that mediates cannabinoid-induced apoptosis of tumor cells. By using a wide array of experimental approaches, we identify the stress-regulated protein p8 (also designated as candidate of metastasis 1) as an essential mediator of cannabinoid antitumoral action and show that p8 upregulation is dependent on de novo-synthesized ceramide. We also observe that p8 mediates its apoptotic effect via upregulation of the endoplasmic reticulum stress-related genes ATF-4, CHOP, and TRB3. Activation of this pathway may constitute a potential therapeutic strategy for inhibiting tumor growth.
引用
收藏
页码:301 / 312
页数:12
相关论文
共 47 条
  • [11] ISOLATION, STRUCTURE, AND PARTIAL SYNTHESIS OF AN ACTIVE CONSTITUENT OF HASHISH
    GAONI, Y
    MECHOULAM, R
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) : 1646 - +
  • [12] Transforming growth factor β-1 enhances Smad transcriptional activity through activation of p8 gene expression
    García-Montero, AC
    Vasseur, S
    Giono, LE
    Canepa, E
    Moreno, S
    Dagorn, JC
    Iovanna, JL
    [J]. BIOCHEMICAL JOURNAL, 2001, 357 (01) : 249 - 253
  • [13] Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs
    Gouazé, V
    Liu, YY
    Prickett, CS
    Yu, JY
    Giuliano, AE
    Cabot, MC
    [J]. CANCER RESEARCH, 2005, 65 (09) : 3861 - 3867
  • [14] Cannabinoids:: Potential anticancer agents
    Guzmán, M
    [J]. NATURE REVIEWS CANCER, 2003, 3 (10) : 745 - 755
  • [15] The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation domain-interacting protein to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter
    Hoffmeister, A
    Ropolo, A
    Vasseur, S
    Mallo, GV
    Bodeker, H
    Ritz-Laser, B
    Dressler, GR
    Vaccaro, MI
    Dagorn, JC
    Moreno, S
    Iovanna, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) : 22314 - 22319
  • [16] International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    Howlett, AC
    Barth, F
    Bonner, TI
    Cabral, G
    Casellas, P
    Devane, WA
    Felder, CC
    Herkenham, M
    Mackie, K
    Martin, BR
    Mechoulam, R
    Pertwee, RG
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 161 - 202
  • [17] Ito Y, 2005, ANTICANCER RES, V25, P833
  • [18] Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes
    Iynedjian, PB
    [J]. BIOCHEMICAL JOURNAL, 2005, 386 : 113 - 118
  • [19] Expression of COM-1/P8 in human breast cancer and its relevance to clinical outcome and ER status
    Jiang, WG
    Watkins, G
    Douglas-Jones, A
    Mokbel, K
    Mansel, RE
    Fodstad, O
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (05) : 730 - 737
  • [20] Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-β connection
    Jiang, WG
    Davies, G
    Fodstad, O
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 330 (01) : 253 - 262